{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:06:10Z","timestamp":1793307970506,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20240231"],"award-info":[{"award-number":["Y20240231"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03833-y","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T10:03:57Z","timestamp":1744279437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Metabolic score for visceral fat is correlated with all-cause and cardiovascular mortality among individuals with non-alcoholic fatty liver disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Chunming","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianpei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"1","key":"3833_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"3833_CR2","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1097\/HEP.0000000000000664","volume":"79","author":"CM Lee","year":"2024","unstructured":"Lee CM, Yoon EL, Kim M, Kang BK, Cho S, Nah EH, Jun DW. Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings. Hepatology. 2024;79(6):1393\u2013400.","journal-title":"Hepatology"},{"key":"3833_CR3","doi-asserted-by":"crossref","unstructured":"Paik JM, Henry L, Younossi Y, Ong J, Alqahtani S, Younossi ZM. The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019. Hepatol Commun 2023, 7(10).","DOI":"10.1097\/HC9.0000000000000251"},{"issue":"4","key":"3833_CR4","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/HEP.0000000000000383","volume":"78","author":"P Hartmann","year":"2023","unstructured":"Hartmann P, Zhang X, Loomba R, Schnabl B. Global and National prevalence of nonalcoholic fatty liver disease in adolescents: an analysis of the global burden of disease study 2019. Hepatology. 2023;78(4):1168\u201381.","journal-title":"Hepatology"},{"issue":"4","key":"3833_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11886-024-02025-6","volume":"26","author":"ECZ Lee","year":"2024","unstructured":"Lee ECZ, Anand VV, Razavi AC, Alebna PL, Muthiah MD, Siddiqui MS, Chew NWS, Mehta A. The global epidemic of metabolic fatty liver disease. Curr Cardiol Rep. 2024;26(4):199\u2013210.","journal-title":"Curr Cardiol Rep"},{"key":"3833_CR6","doi-asserted-by":"crossref","unstructured":"Driessen S, Francque SM, Anker SD, Castro Cabezas M, Grobbee DE, Tushuizen ME, Holleboom AG. Metabolic dysfunction-associated steatotic liver disease and the heart. Hepatology 2023.","DOI":"10.1097\/HEP.0000000000000735"},{"key":"3833_CR7","doi-asserted-by":"publisher","first-page":"102292","DOI":"10.1016\/j.eclinm.2023.102292","volume":"65","author":"JH Moon","year":"2023","unstructured":"Moon JH, Jeong S, Jang H, Koo BK, Kim W. Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study. EClinicalMedicine. 2023;65:102292.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"3833_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR. Metabolic Dysfunction-Associated steatotic liver disease (MASLD): A State-of-the-Art review. J Obes Metab Syndr. 2023;32(3):197\u2013213.","journal-title":"J Obes Metab Syndr"},{"issue":"2","key":"3833_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","volume":"13","author":"N Stefan","year":"2025","unstructured":"Stefan N, Yki-Jarvinen H, Neuschwander-Tetri BA. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diabetes Endocrinol. 2025;13(2):134\u201348.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"3833_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41569-023-00847-5","volume":"20","author":"PL Valenzuela","year":"2023","unstructured":"Valenzuela PL, Carrera-Bastos P, Castillo-Garcia A, Lieberman DE, Santos-Lozano A, Lucia A. Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol. 2023;20(7):475\u201394.","journal-title":"Nat Rev Cardiol"},{"key":"3833_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","volume":"92","author":"KI Avgerinos","year":"2019","unstructured":"Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019;92:121\u201335.","journal-title":"Metabolism"},{"issue":"4","key":"3833_CR12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s13679-023-00527-y","volume":"12","author":"C Koliaki","year":"2023","unstructured":"Koliaki C, Dalamaga M, Liatis S. Update on the obesity epidemic: after the sudden rise, is the upward trajectory beginning to flatten?? Curr Obes Rep. 2023;12(4):514\u201327.","journal-title":"Curr Obes Rep"},{"key":"3833_CR13","doi-asserted-by":"publisher","first-page":"m3324","DOI":"10.1136\/bmj.m3324","volume":"370","author":"A Jayedi","year":"2020","unstructured":"Jayedi A, Soltani S, Zargar MS, Khan TA, Shab-Bidar S. Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies. BMJ. 2020;370:m3324.","journal-title":"BMJ"},{"issue":"10","key":"3833_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jacc.2013.06.027","volume":"62","author":"KA Britton","year":"2013","unstructured":"Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol. 2013;62(10):921\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"3833_CR15","doi-asserted-by":"publisher","first-page":"e019968","DOI":"10.1161\/JAHA.120.019968","volume":"10","author":"AA Kammerlander","year":"2021","unstructured":"Kammerlander AA, Lyass A, Mahoney TF, Massaro JM, Long MT, Vasan RS, Hoffmann U. Sex differences in the associations of visceral adipose tissue and cardiometabolic and cardiovascular disease risk: the Framingham heart study. J Am Heart Assoc. 2021;10(11):e019968.","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"3833_CR16","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1161\/CIRCULATIONAHA.114.015000","volume":"132","author":"TM Abraham","year":"2015","unstructured":"Abraham TM, Pedley A, Massaro JM, Hoffmann U, Fox CS. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation. 2015;132(17):1639\u201347.","journal-title":"Circulation"},{"issue":"5","key":"3833_CR17","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.clnu.2019.07.012","volume":"39","author":"OY Bello-Chavolla","year":"2020","unstructured":"Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vazquez A, Viveros-Ruiz TL, Almeda-Valdes P, Gomez-Velasco D, Mehta R, Elias-Lopez D, Cruz-Bautista I, Roldan-Valadez E, et al. Metabolic score for visceral fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health. Clin Nutr. 2020;39(5):1613\u201321.","journal-title":"Clin Nutr"},{"key":"3833_CR18","doi-asserted-by":"publisher","first-page":"1172323","DOI":"10.3389\/fendo.2023.1172323","volume":"14","author":"R Yang","year":"2023","unstructured":"Yang R, Kuang M, Qiu J, Yu C, Sheng G, Zou Y. Assessing the usefulness of a newly proposed metabolic score for visceral fat in predicting future diabetes: results from the NAGALA cohort study. Front Endocrinol (Lausanne). 2023;14:1172323.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3833_CR19","doi-asserted-by":"publisher","first-page":"111443","DOI":"10.1016\/j.nut.2021.111443","volume":"93","author":"Y Feng","year":"2022","unstructured":"Feng Y, Yang X, Li Y, Wu Y, Han M, Qie R, Huang S, Wu X, Zhang Y, Liu D, et al. Metabolic score for visceral fat: A reliable indicator of visceral obesity for predicting risk for hypertension. Nutrition. 2022;93:111443.","journal-title":"Nutrition"},{"key":"3833_CR20","doi-asserted-by":"crossref","unstructured":"Jia S, Huo X, Zuo X, Zhao L, Liu L, Sun L, Chen X. Association of metabolic score for visceral fat with all-cause mortality, cardiovascular mortality, and cancer mortality: A prospective cohort study. Diabetes Obes Metab 2024.","DOI":"10.1111\/dom.15959"},{"key":"3833_CR21","doi-asserted-by":"publisher","first-page":"110842","DOI":"10.1016\/j.diabres.2023.110842","volume":"203","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Zou H, Guo Y, Luo P, Meng X, Li D, Xiang Y, Mao B, Pan L, Kan R, et al. Associations between metabolic score for visceral fat and the risk of cardiovascular disease and all-cause mortality among populations with different glucose tolerance statuses. Diabetes Res Clin Pract. 2023;203:110842.","journal-title":"Diabetes Res Clin Pract"},{"key":"3833_CR22","unstructured":"Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999\u20132010. Vital Health Stat 1 2013(56):1\u201337."},{"issue":"1","key":"3833_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13098-024-01353-5","volume":"16","author":"C Li","year":"2024","unstructured":"Li C, Xu J. Negative correlation between metabolic score for insulin resistance index and testosterone in male adults. Diabetol Metab Syndr. 2024;16(1):113.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"3833_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, et al. Estimating glomerular filtration rate from serum creatinine and Cystatin C. N Engl J Med. 2012;367(1):20\u20139.","journal-title":"N Engl J Med"},{"issue":"13","key":"3833_CR25","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: A review. JAMA. 2019;322(13):1294\u2013304.","journal-title":"JAMA"},{"issue":"5","key":"3833_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","volume":"63","author":"LA Inker","year":"2014","unstructured":"Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713\u201335.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"3833_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2213-8587(24)00164-5","volume":"12","author":"N Stefan","year":"2024","unstructured":"Stefan N, Schiborn C, Machann J, Birkenfeld AL, Schulze MB. Impact of higher BMI on cardiometabolic risk: does height matter? Lancet Diabetes Endocrinol. 2024;12(8):514\u20135.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3833_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"3833_CR29","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"MC Amato","year":"2010","unstructured":"Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A, AlkaMeSy Study G. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920\u20132.","journal-title":"Diabetes Care"},{"issue":"1","key":"3833_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3833_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","volume":"11","author":"MM Ibrahim","year":"2010","unstructured":"Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11(1):11\u20138.","journal-title":"Obes Rev"},{"issue":"9","key":"3833_CR32","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1097\/MD.0000000000000573","volume":"94","author":"GE Chung","year":"2015","unstructured":"Chung GE, Kim D, Kwark MS, Kim W, Yim JY, Kim YJ, Yoon JH. Visceral adipose tissue area as an independent risk factor for elevated liver enzyme in nonalcoholic fatty liver disease. Med (Baltim). 2015;94(9):e573.","journal-title":"Med (Baltim)"},{"issue":"48","key":"3833_CR33","doi-asserted-by":"publisher","first-page":"e2159","DOI":"10.1097\/MD.0000000000002159","volume":"94","author":"SJ Yu","year":"2015","unstructured":"Yu SJ, Kim W, Kim D, Yoon JH, Lee K, Kim JH, Cho EJ, Lee JH, Kim HY, Kim YJ, et al. Visceral obesity predicts significant fibrosis in patients with nonalcoholic fatty liver disease. Med (Baltim). 2015;94(48):e2159.","journal-title":"Med (Baltim)"},{"issue":"1","key":"3833_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cgh.2015.07.024","volume":"14","author":"D Kim","year":"2016","unstructured":"Kim D, Chung GE, Kwak MS, Seo HB, Kang JH, Kim W, Kim YJ, Yoon JH, Lee HS, Kim CY. Body fat distribution and risk of incident and regressed nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2016;14(1):132\u2013e138134.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"3833_CR35","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1038\/s41366-022-01216-x","volume":"46","author":"Q Chen","year":"2022","unstructured":"Chen Q, Wu Y, Gao Y, Zhang Z, Shi T, Yan B. Effect of visceral adipose tissue mass on coronary artery disease and heart failure: A Mendelian randomization study. Int J Obes (Lond). 2022;46(12):2102\u20136.","journal-title":"Int J Obes (Lond)"},{"key":"3833_CR36","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.2147\/DMSO.S383597","volume":"15","author":"B Li","year":"2022","unstructured":"Li B, Li Y, Zhang Y, Liu P, Song Y, Zhou Y, Ma L. Visceral fat obesity correlates with frailty in Middle-Aged and older adults. Diabetes Metab Syndr Obes. 2022;15:2877\u201384.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"3833_CR37","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12603-020-1330-7","volume":"24","author":"I Chiba","year":"2020","unstructured":"Chiba I, Lee S, Bae S, Makino K, Shinkai Y, Shimada H. Visceral fat accumulation is associated with mild cognitive impairment in Community-Dwelling older Japanese women. J Nutr Health Aging. 2020;24(3):352\u20137.","journal-title":"J Nutr Health Aging"},{"key":"3833_CR38","doi-asserted-by":"publisher","first-page":"922931","DOI":"10.3389\/fendo.2022.922931","volume":"13","author":"RK Saad","year":"2022","unstructured":"Saad RK, Ghezzawi M, Horanieh R, Khamis AM, Saunders KH, Batsis JA, Chakhtoura M. Abdominal visceral adipose tissue and All-Cause mortality: A systematic review. Front Endocrinol (Lausanne). 2022;13:922931.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"3833_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ajcnut.2023.07.001","volume":"118","author":"L Li","year":"2023","unstructured":"Li L, Li W, Xu D, He H, Yang W, Guo H, Liu X, Ji W, Song C, Xu H, et al. Association between visceral fat area and cancer prognosis: A Population-Based multicenter prospective study. Am J Clin Nutr. 2023;118(3):507\u201317.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"3833_CR40","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/j.clnu.2020.09.016","volume":"40","author":"H Feng","year":"2021","unstructured":"Feng H, Wang X, Zhao T, Mao L, Hui Y, Fan X, Lin L, Zhao W, Jiang K, Wang B, et al. Myopenic obesity determined by visceral fat area strongly predicts long-term mortality in cirrhosis. Clin Nutr. 2021;40(4):1983\u20139.","journal-title":"Clin Nutr"},{"key":"3833_CR41","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.2147\/DMSO.S421623","volume":"16","author":"C Torun","year":"2023","unstructured":"Torun C, Ankarali H, Castur L, Uzunlulu M, Erbakan AN, Akbas MM, Gunduz N, Dogan MB, Oguz A. Is metabolic score for visceral fat (METS-VF) a better index than other adiposity indices for the prediction of visceral adiposity. Diabetes Metab Syndr Obes. 2023;16:2605\u201315.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"3833_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12933-023-01807-6","volume":"22","author":"NE Antonio-Villa","year":"2023","unstructured":"Antonio-Villa NE, Juarez-Rojas JG, Posadas-Sanchez R, Reyes-Barrera J, Medina-Urrutia A. Visceral adipose tissue is an independent predictor and mediator of the progression of coronary calcification: a prospective sub-analysis of the GEA study. Cardiovasc Diabetol. 2023;22(1):81.","journal-title":"Cardiovasc Diabetol"},{"key":"3833_CR43","doi-asserted-by":"publisher","first-page":"1281524","DOI":"10.3389\/fendo.2023.1281524","volume":"14","author":"M Kuang","year":"2023","unstructured":"Kuang M, Qiu J, Li D, Hu C, Zhang S, Sheng G, Zou Y. The newly proposed metabolic score for visceral fat is a reliable tool for identifying non-alcoholic fatty liver disease, requiring attention to age-specific effects in both sexes. Front Endocrinol (Lausanne). 2023;14:1281524.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3833_CR44","doi-asserted-by":"publisher","first-page":"1052736","DOI":"10.3389\/fendo.2022.1052736","volume":"13","author":"P Yu","year":"2022","unstructured":"Yu P, Meng X, Kan R, Wang Z, Yu X. Association between metabolic scores for visceral fat and chronic kidney disease: A cross-sectional study. Front Endocrinol (Lausanne). 2022;13:1052736.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3833_CR45","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.2147\/DMSO.S370222","volume":"15","author":"L Feng","year":"2022","unstructured":"Feng L, Chen T, Wang X, Xiong C, Chen J, Wu S, Ning J, Zou H. Metabolism score for visceral fat (METS-VF): A new predictive surrogate for CKD risk. Diabetes Metab Syndr Obes. 2022;15:2249\u201358.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"10","key":"3833_CR46","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.numecd.2020.06.001","volume":"30","author":"XZ Liu","year":"2020","unstructured":"Liu XZ, Chen DS, Xu X, Li HH, Liu LY, Zhou L, Fan J. Longitudinal associations between metabolic score for visceral fat and hyperuricemia in non-obese adults. Nutr Metab Cardiovasc Dis. 2020;30(10):1751\u20137.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3833_CR47","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.2147\/DMSO.S383907","volume":"15","author":"R Zhang","year":"2022","unstructured":"Zhang R, Guan Q, Zhang M, Ding Y, Tang Z, Wang H, Zhang W, Chen Y, Jiang R, Cui Y, et al. Association between Triglyceride-Glucose index and risk of metabolic Dysfunction-Associated fatty liver disease: A cohort study. Diabetes Metab Syndr Obes. 2022;15:3167\u201379.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"3833_CR48","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despres JP, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715\u201325.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3833_CR49","doi-asserted-by":"crossref","unstructured":"Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, Beguinot F, Miele C. Adipose tissue dysfunction as determinant of Obesity-Associated metabolic complications. Int J Mol Sci 2019, 20(9).","DOI":"10.3390\/ijms20092358"},{"key":"3833_CR50","doi-asserted-by":"publisher","first-page":"101259","DOI":"10.1016\/j.arr.2021.101259","volume":"67","author":"H Von Bank","year":"2021","unstructured":"Von Bank H, Kirsh C, Simcox J. Aging adipose: depot location dictates age-associated expansion and dysfunction. Ageing Res Rev. 2021;67:101259.","journal-title":"Ageing Res Rev"},{"issue":"6","key":"3833_CR51","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S2213-8587(23)00086-4","volume":"11","author":"N Stefan","year":"2023","unstructured":"Stefan N, Schulze MB. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol. 2023;11(6):426\u201340.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"3833_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13098-024-01574-8","volume":"17","author":"D Xing","year":"2025","unstructured":"Xing D, Xu J, Weng X, Weng X. Correlation between estimated glucose disposal rate, insulin resistance, and cardiovascular mortality among individuals with metabolic syndrome: a population-based analysis, evidence from NHANES 1999\u20132018. Diabetol Metab Syndr. 2025;17(1):11.","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"3833_CR53","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"6","key":"3833_CR54","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1017\/S0007114521004116","volume":"128","author":"Y Feng","year":"2022","unstructured":"Feng Y, Yang X, Li Y, Wu Y, Han M, Qie R, Huang S, Wu X, Zhang Y, Zhang J, et al. Metabolic score for visceral fat: a novel predictor for the risk of type 2 diabetes mellitus. Br J Nutr. 2022;128(6):1029\u201336.","journal-title":"Br J Nutr"},{"issue":"9","key":"3833_CR55","doi-asserted-by":"publisher","first-page":"e12997","DOI":"10.1111\/eci.12997","volume":"48","author":"X Unamuno","year":"2018","unstructured":"Unamuno X, Gomez-Ambrosi J, Rodriguez A, Becerril S, Fruhbeck G, Catalan V. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest. 2018;48(9):e12997.","journal-title":"Eur J Clin Invest"},{"key":"3833_CR56","doi-asserted-by":"publisher","first-page":"150437","DOI":"10.1016\/j.bbrc.2024.150437","volume":"733","author":"CE Miracle","year":"2024","unstructured":"Miracle CE, McCallister CL, Egleton RD, Salisbury TB. Mechanisms by which obesity regulates inflammation and anti-tumor immunity in cancer. Biochem Biophys Res Commun. 2024;733:150437.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3833_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.atherosclerosis.2013.12.023","volume":"233","author":"N Alexopoulos","year":"2014","unstructured":"Alexopoulos N, Katritsis D, Raggi P. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis. 2014;233(1):104\u201312.","journal-title":"Atherosclerosis"},{"key":"3833_CR58","doi-asserted-by":"publisher","first-page":"1187735","DOI":"10.3389\/fcvm.2023.1187735","volume":"10","author":"A Cesaro","year":"2023","unstructured":"Cesaro A, De Michele G, Fimiani F, Acerbo V, Scherillo G, Signore G, Rotolo FP, Scialla F, Raucci G, Panico D, et al. Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options. Front Cardiovasc Med. 2023;10:1187735.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"3833_CR59","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","volume":"35","author":"N Stefan","year":"2023","unstructured":"Stefan N, Schick F, Birkenfeld AL, Haring HU, White MF. The role of hepatokines in NAFLD. Cell Metab. 2023;35(2):236\u201352.","journal-title":"Cell Metab"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03833-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03833-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03833-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:14:12Z","timestamp":1744287252000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03833-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3833"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03833-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The National Center for Health Statistics Ethics Review Board has approved the implementation of NHANES, and every participant signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}